Clinical Trials Directory

Trials / Unknown

UnknownNCT02267980

Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy

Turgut Ozal Medical Center Department of Anesthesiology and Reanimation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Inonu University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The investigators evaluate the effects of a subanesthetic dose of ketamine, administered as an adjunct to sevoflurane, on duration of seizure activity, hemodynamic profile and recovery times during electroconvulsive therapy (ECT) in patients with major depression.

Detailed description

Patients will randomly allocate, to either a sevoflurane-ketamine (Group SK), sevoflurane-saline (Group SS) receiving group. Mean arterial pressure (MAP) and heart rate (HR) will record prior to anesthetic induction (T1); following anesthetic induction (T2); and 0, 1, 3, and 10 min after the seizure has ended (T3, T4, T5, and T6, respectively). Motor and EEG seizure durations will be recorded.

Conditions

Interventions

TypeNameDescription
DRUGSevofluraneInhalation anesthetic agent
DRUGKetamineIntravenous anesthetic agent
DRUGSalineIsotonic solution for placebo group

Timeline

Start date
2014-07-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2014-10-20
Last updated
2014-10-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02267980. Inclusion in this directory is not an endorsement.